Lv1
40 积分 2024-06-19 加入
ASCEND-Eye
14小时前
待确认
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
18天前
已关闭
In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo
2个月前
已完结
Explaining the high rate of progression from prediabetes to type 2 diabetes in China
6个月前
已完结
Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities
6个月前
已完结
Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities
6个月前
已完结
Effects of Intermittent Fasting on Health, Aging, and Disease
6个月前
已完结
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
6个月前
已完结
SGLT2 inhibitors may prevent diabetes
6个月前
已完结
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
6个月前
已完结
皖公网安备34019202002308
